This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial
Clinical Infectious Diseases · 2024
Thermoneutral Housing and a Western Diet Combination Exacerbates Dysferlin-Deficient Muscular Dystrophy.
Muscle & nerve · 2022
Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.
Critical care medicine · 2021
Latest funding
- $500,000
COVID-19 And Severe Community-Acquired Pneumonia Dynamic Evaluation Study (CASCADES - ARBS CORONA III)
CIHR · 2021 · Co-investigator
- $422,084
Diagnosing the onset of severe Covid-19 disease
CIHR · 2020 · Co-investigator
- $3,456,541
HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)
CIHR · 2020 · Co-investigator
21 publications.
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial
Tran KC, Asfar P, Cheng M, Demiselle J, Singer J, Lee T, Sweet D, Boyd J, Walley K, Haljan G
Thermoneutral Housing and a Western Diet Combination Exacerbates Dysferlin-Deficient Muscular Dystrophy.
Donen GS, White Z, Sauge E, Ritso M, Theret M, Boyd J, Devlin AM, Rossi FMV, Bernatchez P
Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.
Cheng MP, Cau A, Lee TC, Brodie D, Slutsky A, Marshall J, Murthy S, Lee T, Singer J, Demir KK, Boyd J, Ohm H, Maslove D, Goffi A, Bogoch II, Sweet DD, Walley KR, Russell JA, Angiotensin Receptor Blocker Coronavirus Study (ARBs) CORONA I
Response by Brunham et al to Letter Regarding Article, "Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis".
Brunham LR, Trinder M, Rensen PCN, Boyd J
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.
Lee T, Cau A, Cheng MP, Levin A, Lee TC, Vinh DC, Lamontagne F, Singer J, Walley KR, Murthy S, Patrick D, Rewa OG, Winston BW, Marshall J, Boyd J, Tran K, Kalil AC, Mcculoh R, Fowler R, Luther JM, Russell JA, ARBs CORONA
Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency Department.
Kahn F, Tverring J, Mellhammar L, Wetterberg N, Bläckberg A, Studahl E, Hadorn N, Kahn R, Nueesch S, Jent P, Ricklin ME, Boyd J, Christensson B, Sendi P, Åkesson P, Linder A
Survey of non-resuscitation fluids administered during septic shock: a multicenter prospective observational study.
Lindén-Søndersø A, Jungner M, Spångfors M, Jan M, Oscarson A, Choi S, Kander T, Undén J, Griesdale D, Boyd J, Bentzer P
Once or Twice Daily Screening for Weaning the Critically Ill-Have We Set Our Sights Too Low?
Genga KR, Boyd J, Russell JA
Man With Abdominal Pain.
Barbic D, Boyd J, Scheuermeyer FX
Is Heparin-Binding Protein Inhibition a Mechanism of Albumin's Efficacy in Human Septic Shock?
Fisher J, Linder A, Bentzer P, Boyd J, Kong HJ, Lee T, Walley KR, Russell JA
COVID-19 And Severe Community-Acquired Pneumonia Dynamic Evaluation Study (CASCADES - ARBS CORONA III)
Principal investigators: Russell, James A
Keywords: Bacterial Community-Acquired Pneumonia; Chronic Kidney Disease; Chronic Obstructive Pulmonary Disease; Covid-19; Individuals Experiencing Homelessness; Ras Pathway; Sepsis
Diagnosing the onset of severe Covid-19 disease
Principal investigators: Hancock, Robert Ernest W
Keywords: Ards; Cellular Reprogramming; Covid-19; Diagnostics; Endotypes; Organ Failure; Pathophysiology; Rna-Seq; Sepsis; Transcriptomics
HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)
Principal investigators: Russell, James A
Keywords: Arbs; Biomarkers; Covid-19; Host Response; Losartan; Randomized Controlled Trial
SONRIS 2.0: Sepsis Outcomes Network to Improve Survival
Principal investigators: Boyd, John H; Brunham, Liam R; Hux, Janet E; Lovshin, Julie A; Rush, Barret; Russell, James A; Senior, Peter A; Drucker, Daniel J; Kumar, Anand; Walley, Keith R
Keywords: Diabetes; Infectious Disease; Lipoproteins; Nutrition; Sepsis
CETP Inhibition as a novel treatment to remove pathogen lipids and improve survival in sepsis
Principal investigators: Brunham, Liam R; Boyd, John H
Keywords: Animal Models; Cetp; Hdl; Lipids; Lps; Sepsis
Cholesteryl ester transfer protein as a novel regulator, predictor, and therapeutic target of sepsis
Principal investigators: Trinder, Mark E
Keywords: Cholesteryl Ester Transfer Protein; Crispr/Cas9; Genetics; High-Density Lipoproteins; Innate Immunity; Lipopolysaccharide; Next-Generation Sequencing; Quantitative Reverse Transcription Pcr; Sepsis; Western Blotting
The critical role of plasma cholesterol in the pathogenesis of muscular dystrophy
Principal investigators: Bernatchez, Pascal N
Keywords: Cholesterol; Duchenne Muscular Dystrophy; Limb-Girdle Muscular Dystrophy; Lipoproteins
Organ donation after cardiac death: optimizing the donor heart.
Principal investigators: Boyd, John H
Keywords: Cardiac Physiology; Heart Transplant; Ischemia Reperfusion Injury
Translational research to improve sepsis outcomes
Principal investigators: Walley, Keith R
Keywords: Endotoxins; Genotype; Inflammation; Pcsk9; Sepsis
A Novel Laboratory Model of Organ Donation After Circulatory Death (DCD): Investigating Cardiac Injury Associated With the DCD Process, Viability of DCD Hearts, and the Impact of Pre-Treatment Strategies.
Principal investigators: Kearns, Mark J
Keywords: Cardiac Science; Cardiac Surgery; Cardiovascular Physiology; Donation After Circulatory Death (Dcd); Ischemia; Ischemic Pre-Conditioning; Organ Donation; Transplantation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Critical Care Medicine
- Infectious Diseases/Internal Medicine
- Médecine interne
- Nephrology
- Family Medicine and Emergency Medicine
- School of Population and Public Health
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Francois Lamontagne
Médecine interne
2 shared papers, latest 2024
Robert Fowler
Infectious Diseases/Internal Medicine
2 shared papers, latest 2024
John Marshall
Critical Care Medicine
2 shared papers, latest 2021
David Patrick
School of Population and Public Health
1 shared papers, latest 2021
Srinivas Murthy
Faculty
1 shared papers, latest 2021
Barret Rush
Medicine
1 shared papers, latest 2018
Matthew Cheng
Infectious Diseases
1 shared papers, latest 2024
Karen Tran
Faculty
1 shared papers, latest 2021
David Maslove
Critical Care Medicine
1 shared papers, latest 2021
Jennifer Tsang
Medicine
1 shared papers, latest 2024
Arthur Slutsky
Critical Care Medicine
1 shared papers, latest 2021
Donald Griesdale
Medicine
1 shared papers, latest 2019
Nick Daneman
Infectious Diseases/Internal Medicine
1 shared papers, latest 2024
Adeera Levin
Nephrology
1 shared papers, latest 2021
Pascal Bernatchez
Anesthesiology, Pharmacology and Therapeutics
1 shared papers, latest 2022
Keith Walley
Medicine
1 shared papers, latest 2024
Alexis Turgeon
Family Medicine and Emergency Medicine
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.